Prulifloxacin molecular structure

Prulifloxacin

Also known as: Quisnon, Unidrox, Pruquin, Prulix

CAS Number: 123447-62-1

Fluoroquinolone Antibacterial (Prodrug)

Pharmacopeia Standards

JPCPIP

Mechanism of Action

Prulifloxacin is an ester prodrug hydrolysed by intestinal and hepatic esterases to the active metabolite ulifloxacin, which inhibits DNA gyrase and topoisomerase IV. Prodrug esterification improves oral absorption relative to the parent acid. The active species produces concentration-dependent bactericidal killing across Gram-negative uropathogens and respiratory organisms.

Technical Specifications

Generic / INN NamePrulifloxacin
CAS Registry Number123447-62-1
Molecular FormulaC21H20FN3O6S
Molecular Weight461.46 g/mol g/mol
Typical PurityNLT 98.5% by HPLC on the anhydrous basis; ulifloxacin (hydrolysis) impurity NMT 0.5%
Storage ConditionsStore below 25 degrees C in nitrogen-flushed double LDPE-lined containers, protected from moisture and light
Shelf Life36 months from date of manufacture
CategoryFluoroquinolones

Specifications are indicative and intended for sourcing reference only. Always confirm against the supplier's Certificate of Analysis and the applicable pharmacopeial monograph before issuing a purchase specification.

Typical Applications

Oral tablets, marketed chiefly in Japan, Italy, China and India for urinary and respiratory tract indications. Formulators must control hydrolysis of the dioxolone ester during granulation and storage.

Manufacturers (0+)

View all →
No manufacturers listed yet. Register your company to appear here.